EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model

You-Lin Tain iD, Chi-I Chang, Chih-Yao Hou iD, Guo-Ping Chang-Chien iD, Sufan Lin, Chien-Ning Hsu iD

Nutrients · 2023

DOI: 10.3390/nu15030635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von You-Lin Tain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan. Hauptthemen laut MEDLINE: Hypertension, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Chang Gung Memorial Hospital and National Pingtung University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) remains a public health problem. Certain dietary supplements can assist in the prevention of CKD progression. In this regard, resveratrol is a polyphenol and has a potential therapeutic role in alleviating CKD. We previously utilized butyrate in order to improve the bioavailability of resveratrol via esterification and generated a resveratrol butyrate monoester (RBM). In this study, the hypothesis that RBM supplementation is able to protect against kidney dysfunction and hypertension was tested by using an adenine-induced CKD model. For this purpose, three-week-old male Sprague Dawley rats (n = 40) were equally categorized into: group 1—CN (sham control); group 2—CKD (adenine-fed rats); group 3—REV (CKD rats treated with 50 mg/L resveratrol); group 4—MEL (CKD rats treated with 25 mg/L RBM); and group 5—MEH (CKD rats treated with 50 mg/L RBM). At the end of a 12-week period, the rats were then euthanized. The adenine-fed rats displayed hypertension and kidney dysfunction, which were attenuated by dietary supplementation with RBM. The CKD-induced hypertension coincided with: decreased nitric oxide (NO) bioavailability; augmented renal protein expression of a (pro)renin receptor and angiotensin II type 1 receptor; and increased oxidative stress damage. Additionally, RBM and resveratrol supplementation shaped distinct gut microbiota profiles in the adenine-treated CKD rats. The positive effect of high-dose RBM was shown together with an increased abundance of the genera Duncaniella, Ligilactobacillus, and Monoglobus, as well as a decrease in Eubacterium and Schaedierella. Importantly, the mechanism of action of the RBM supplementation may be related to the restoration of NO, rebalancing of the RAS, a reduction in oxidative stress, and alterations to the gut microbiota. Moreover, RBM supplementation shows promise for the purposes of improving CKD outcomes and hypertension. As such, further translation to human studies is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionRenal Insufficiency, ChronicAnimalsMaleRatsAdenineButyratesDietary SupplementsKidneyOxidative StressRats, Sprague-DawleyResveratrol

Stichwörter der Autor:innen

chronic kidney diseasegut microbiotahypertensionnitric oxideoxidative stressrenin-angiotensin systemresveratrol

Substanzen

AdenineButyratesResveratrol

Autor:innen und Institutionen

  • Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan 330, Taiwan.
  • Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 912, Taiwan.
  • Department of Seafood Science, National Kaohsiung University of Science and Technology, Kaohsiung 811, Taiwan.
  • Institute of Environmental Toxin and Emerging-Contaminant, Cheng Shiu University, Kaohsiung 833, Taiwan.
  • Super Micro Mass Research and Technology Center, Cheng Shiu University, Kaohsiung 833, Taiwan.

ORCID-Profile: You-Lin Tain, Chih-Yao Hou, Guo-Ping Chang-Chien, Chien-Ning Hsu

Förderung

  • Kaohsiung Chang Gung Memorial Hospital and National Pingtung University of Science and Technology

Zitieren

APA

Tain, Y. L., Chang, C. I., Hou, C. Y., Chang-Chien, G. P., Lin, S., & Hsu, C. N. (2023). Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model. Nutrients. https://doi.org/10.3390/nu15030635

Vancouver

Tain YL, Chang CI, Hou CY, Chang-Chien GP, Lin S, Hsu CN. Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model. Nutrients. 2023. doi:10.3390/nu15030635

BibTeX
@article{Tain2023,
  author = {Tain, You-Lin and Chang, Chi-I and Hou, Chih-Yao and Chang-Chien, Guo-Ping and Lin, Sufan and Hsu, Chien-Ning},
  title = {Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15030635}
}
Kostenlos starten →